000 | 01959 a2200529 4500 | ||
---|---|---|---|
005 | 20250517022020.0 | ||
264 | 0 | _c20150706 | |
008 | 201507s 0 0 eng d | ||
022 | _a1090-2430 | ||
024 | 7 |
_a10.1016/j.expneurol.2015.02.036 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSanna, M D | |
245 | 0 | 0 |
_aSpinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy. _h[electronic resource] |
260 |
_bExperimental neurology _cMay 2015 |
||
300 |
_a53-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnalgesics, Non-Narcotic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-HIV Agents _xtoxicity |
650 | 0 | 4 |
_aApomorphine _xtherapeutic use |
650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xpharmacology |
650 | 0 | 4 |
_aELAV Proteins _xgenetics |
650 | 0 | 4 | _aELAV-Like Protein 4 |
650 | 0 | 4 |
_aExploratory Behavior _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation _xphysiology |
650 | 0 | 4 |
_aHyperalgesia _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNeuroblastoma _xpathology |
650 | 0 | 4 |
_aPain _xchemically induced |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aRyanodine Receptor Calcium Release Channel _xmetabolism |
650 | 0 | 4 |
_aSpinal Cord _xphysiology |
650 | 0 | 4 |
_aZalcitabine _xtoxicity |
700 | 1 | _aPeroni, D | |
700 | 1 | _aQuattrone, A | |
700 | 1 | _aGhelardini, C | |
700 | 1 | _aGaleotti, N | |
773 | 0 |
_tExperimental neurology _gvol. 267 _gp. 53-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2015.02.036 _zAvailable from publisher's website |
999 |
_c24702459 _d24702459 |